Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) IPO

Latigo Biotherapeutics, Inc.

IPO

Priced at US$18.00 a share on Aug 6, 2026.

Price
US$18.00 a share
Shares offered
19,200,000 shares of common stock
Offering size
US$345.6 million
Underwriters' option
Up to 2,880,000 more shares
Listing
LTGO on the Nasdaq Global Select Market
Underwriters
Goldman Sachs & Co. LLC, Jefferies, Leerink Partners, Guggenheim Securities · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceMar 27, 2026
Filed publiclyJul 17, 2026
Amended twiceNewest Aug 4, 2026
Shares registered with an exchangeAug 4, 2026
Declared effective by the SECAug 6, 2026
Final prospectus, with the priceAug 7, 2026

From the cover of the final prospectus (424B4) filed Aug 7, 2026